310 related articles for article (PubMed ID: 22110211)
1. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
[TBL] [Abstract][Full Text] [Related]
2. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
Lin SY; Tsai CS; Chang YC; Ng KK; Chang TC; Kao WH; Lai CH; Hong JH
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):577-85. PubMed ID: 25936817
[TBL] [Abstract][Full Text] [Related]
3. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK
Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
5. False negative rate at
Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
7. Added value of para-aortic surgical staging compared to
De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
[TBL] [Abstract][Full Text] [Related]
8. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
[TBL] [Abstract][Full Text] [Related]
10. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
11. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Lu P; Sun Y; Sun Y; Yu L
Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
Perez-Medina T; Pereira A; Mucientes J; García-Espantaleón M; Jiménez JS; Calles L; Rodríguez B; Iglesias E
Int J Gynecol Cancer; 2013 Jan; 23(1):170-5. PubMed ID: 23196756
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
[TBL] [Abstract][Full Text] [Related]
16. A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
Small W; Vern TZ; Rademaker A; Nemcek A; Spies S; Schink JC; Singh DK; Lurain JR
Am J Clin Oncol; 2010 Feb; 33(1):89-93. PubMed ID: 19730352
[TBL] [Abstract][Full Text] [Related]
17. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
18. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
Lee HJ; Park JY; Lee JJ; Kim MH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2016 Mar; 140(3):409-14. PubMed ID: 26777990
[TBL] [Abstract][Full Text] [Related]
19. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
[TBL] [Abstract][Full Text] [Related]
20. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]